|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/415 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/415 | (2013.01) | ||
| C07D 231/12 | (2006.01) |
| (11) | Patento numeris | 3541380 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17870813.7 |
| Europos patento paraiškos padavimo data | 2017-11-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-09-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CA2017/051368 |
| Data | 2017-11-16 |
| (87) | Numeris | WO 2018/090137 |
| Data | 2018-05-24 |
| (30) | Numeris | Data | Šalis |
| 201662423019 P | 2016-11-16 | US |
| (72) |
LEMIRE, Isabelle , CA
HARVEY, Michael , CA
GROGAN, Donna Roy , US
DESJARDINS, Clarissa , CA
|
| (73) |
Clementia Pharmaceuticals Inc. ,
1000 de la Gauchetière O, suite 1200, Montreal, QC H3B 4W5,
CA
|
| (54) | METHODS FOR TREATING MULTIPLE OSTEOCHONDROMA (MO) |
| METHODS FOR TREATING MULTIPLE OSTEOCHONDROMA (MO) |